RETRACTED ARTICLE: WELL.ME - Wellbeing therapy based on real-time personalized mobile architecture, vs. cognitive therapy, to reduce psychological distress and promote healthy lifestyle in cardiovascular disease patients: study protocol for a randomized controlled trial
- 4.9k Downloads
There is compelling evidence that psychological factors may have the same or even greater impact on the possibility of adverse events on cardiac diseases (CD) than other traditional clinical risk factors. Anxiety and depression are predictors of short- and long-term adverse outcomes, increased risk for higher rates of in-hospital complications, re-infarction, malignant arrhythmias, and mortality in CD patients. Despite researchers finding that cognitive behavior therapy (CBT) reduced depressive and anxiety symptoms, the fact that such results are maintained only in the short term and the lack of maintenance of the long-term affects the absence of changes in lifestyles, preventing the possibility of a wide generalization of results. Recently wellbeing therapy (WBT) has been proposed as a useful approach to improve healthy lifestyle behaviors and reduce psychological distress.
The present randomized controlled study will test WBT, in comparison with CBT, as far as the reduction of symptoms of depression, anxiety and psychological distress, and the improvement of lifestyle behaviors and quality of life in cardiac patients are concerned. Moreover, innovations in communication technologies allow patients to be constantly followed in real life. Therefore WBT based on personalized mobile technology will allow the testing of its effectiveness in comparison with usual WBT.
The present study is a large outpatient study on the treatment of co-morbid depression, anxiety, and psychological distress in cardiac patients. The most important issues of this study are its randomized design, the focus on promotion of health-related behaviors, and the use of innovative technologies supporting patients’ wellbeing in real life and in a continuous way. First results are expected in 2012.
ClinicalTrials.gov Identifier: NCT01543815.
KeywordsAnxiety Depression Psychological distress Cognitive behavior therapy Wellbeing therapy Mobile technology Cardiac disease
Cognitive behavioral therapy
Coronary heart disease
Diagnostic and Statistical Manual, 4th edition
Diagnostic Criteria for Psychosomatic Research
Generalized Anxiety Disorder 7
Health-related quality of life
Mini International Neuropsychiatric Interview
WBT version based on personalized mobile technology
New York Heart association
Psychological General Wellbeing Index
Minnesota Living with Heart Failure Questionnaire
Patient Health Questionnaire 9
Psychological Wellbeing Scale
Statistical Package for Social Sciences
- 6.Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O’Connor CM: Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001, 161: 1849-1856. 10.1001/archinte.161.15.1849.CrossRefGoogle Scholar
- 9.Whang W, Shimbo D, Kronish IM, Duvall WL, Julien H, Iyer P, Burg MM, Davidson KW: Depressive symptoms and all-cause mortality in unstable angina pectoris (from the Coronary Psychosocial Evaluation Studies [COPES]). Am J Cardiol. 2010, 106: 1104-1107. 10.1016/j.amjcard.2010.06.015.CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Nabi H, Shipley MJ, Vahtera J, Hall M, Korkeila J, Marmot MG, Kivimaki M, Singh-Manoux A: Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Heart. 2010, 96: 1645-1650. 10.1136/hrt.2010.198507.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JG: Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail. 2005, 7: 803-808. 10.1016/j.ejheart.2005.03.001.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, Blazing MA, Gaulden LH, Califf RM, Krishnan RR, O’Connor CM: Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004, 110: 3452-3456. 10.1161/01.CIR.0000148138.25157.F9.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Manzoni GM, Villa V, Compare A, Castelnuovo G, Nibbio F, Titon AM, Molinari E, Gondoni LA: Short-term effects of a multi-disciplinary cardiac rehabilitation programme on psychological well-being, exercise capacity and weight in a sample of obese in-patients with coronary heart disease: a practice-level study. Psychol Health Med. 2011, 16: 178-189. 10.1080/13548506.2010.542167.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Lesperance F, Frasure-Smith N, Koszycki D, Laliberte MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC, CREATE Investigators: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007, 297: 367-379. 10.1001/jama.297.4.367.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N, Enhancing Recovering in Coronary Heart Disease Patients Investigators (ENRICHD): Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery In Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003, 289: 3106-3116.CrossRefGoogle Scholar
- 30.Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive therapy of depression. 1979, New York, NY: Guilford PressGoogle Scholar
- 32.Lamers F, Jonkers CC, Bosma H, Penninx BW, Knottnerus JA, van Eijk JT: Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol. 2008, 61: 679-687. 10.1016/j.jclinepi.2007.07.018.CrossRefGoogle Scholar
- 38.Dupuy HJ: The Psychological General Well-being (PGWB) Index. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Edited by: Wenger NK, Mattson ME, Furburg CD, Elinson J. 1990, New York, NY: Le Jacq Publishing, 170-183.Google Scholar
- 40.Omvik P, Thaulow E, Herlan O, Eide I, Midha R, Turner R: Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study. J Hypertens. 1993, 11: 103-113. 10.1097/00004872-199301000-00015.CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Rector TS, Cohn JN: Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992, 124: 1017-1025. 10.1016/0002-8703(92)90986-6.CrossRefPubMedPubMedCentralGoogle Scholar
- 42.Cohen J: Statistical power analysis for the behavioural sciences. 1988, Hillsdale, NJ: Erlbaum, 2Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.